Takeshi Matsubara

Molecular Markers of Tubulointerstitial Fibrosis and Tubular Cell Damage in Patients with Chronic Kidney Disease

Shunsaku Nakagawa, Kumiko Nishihara, Hitomi Miyata et al. · PLoS ONE · 2015 · 205 citations · Full text

Glomerular Disease, Molecular Markers, Renal Pathology +19

Inhibition of MCP-1/CCR2 pathway ameliorates the development of diabetic nephropathy

Hiroshi Kanamori, Takeshi Matsubara, Akira Mima et al. · Biochemical and Biophysical Research Communications · 2007 · 161 citations

Inflammation, Metabolic Syndrome, Mcp-1/ccr2 Pathway +11

Gas6 induces Akt/mTOR-mediated mesangial hypertrophy in diabetic nephropathy

Kojiro Nagai, Takeshi Matsubara, Akira Mima et al. · Kidney International · 2005 · 147 citations · Full text

Akt/mtor-mediated Mesangial Hypertrophy, Medicine, Diabetes +5

Growth Arrest-specific Gene 6 Is Involved in Glomerular Hypertrophy in the Early Stage of Diabetic Nephropathy

Kojiro Nagai, Hidenori Arai, Motoko Yanagita et al. · Journal of Biological Chemistry · 2003 · 106 citations · Full text

Increased Expression of Fractalkine is Correlated with a Better Prognosis and an Increased Number of Both CD8+ T Cells and Natural Killer Cells in Gastric Adenocarcinoma

Miki Hyakudomi, Takeshi Matsubara, Ryoji Hyakudomi et al. · Annals of Surgical Oncology · 2008 · 95 citations

Cancer Immunosurveillance, Gastrointestinal Oncology, T-regulatory Cell +9